vs
Arcutis Biotherapeutics, Inc.（ARQT）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
Ribbon Communications Inc.的季度营收约是Arcutis Biotherapeutics, Inc.的1.3倍（$162.6M vs $129.5M），Ribbon Communications Inc.净利率更高（54.8% vs 13.4%，领先41.3%），Arcutis Biotherapeutics, Inc.同比增速更快（81.5% vs -10.3%），过去两年Arcutis Biotherapeutics, Inc.的营收复合增速更高（61.6% vs -8.1%）
Arcutis Biotherapeutics是一家临床阶段生物制药企业，专注于开发和商业化免疫介导皮肤病领域的创新处方疗法，产品管线覆盖银屑病、特应性皮炎、斑秃等适应症，主要服务美国市场的患者及医疗服务提供者，填补皮肤科诊疗领域的未满足需求。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
ARQT vs RBBN — 直观对比
营收规模更大
RBBN
是对方的1.3倍
$129.5M
营收增速更快
ARQT
高出91.8%
-10.3%
净利率更高
RBBN
高出41.3%
13.4%
两年增速更快
ARQT
近两年复合增速
-8.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $129.5M | $162.6M |
| 净利润 | $17.4M | $89.1M |
| 毛利率 | 91.0% | 42.9% |
| 营业利润率 | 14.2% | 37.6% |
| 净利率 | 13.4% | 54.8% |
| 营收同比 | 81.5% | -10.3% |
| 净利润同比 | 261.2% | — |
| 每股收益（稀释后） | $0.14 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARQTRBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | $129.5M | $227.3M | ||
| Q3 25 | $99.2M | $215.4M | ||
| Q2 25 | $81.5M | $220.6M | ||
| Q1 25 | $65.8M | $181.3M | ||
| Q4 24 | $71.4M | $251.4M | ||
| Q3 24 | $44.8M | $210.2M | ||
| Q2 24 | $30.9M | $192.6M |
净利润ARQTRBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | $17.4M | — | ||
| Q3 25 | $7.4M | $-12.1M | ||
| Q2 25 | $-15.9M | $-11.1M | ||
| Q1 25 | $-25.1M | $-26.2M | ||
| Q4 24 | $-10.8M | — | ||
| Q3 24 | $-41.5M | $-13.4M | ||
| Q2 24 | $-52.3M | $-16.8M |
毛利率ARQTRBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | 91.0% | 53.3% | ||
| Q3 25 | 91.2% | 50.1% | ||
| Q2 25 | 90.8% | 49.6% | ||
| Q1 25 | 86.6% | 45.4% | ||
| Q4 24 | 90.3% | 55.7% | ||
| Q3 24 | 87.7% | 52.1% | ||
| Q2 24 | 88.8% | 50.8% |
营业利润率ARQTRBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | 14.2% | 4.1% | ||
| Q3 25 | 8.6% | 1.3% | ||
| Q2 25 | -17.9% | 1.9% | ||
| Q1 25 | -37.3% | -10.8% | ||
| Q4 24 | -10.7% | 13.2% | ||
| Q3 24 | -87.3% | -0.4% | ||
| Q2 24 | -162.3% | -1.0% |
净利率ARQTRBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | 13.4% | — | ||
| Q3 25 | 7.5% | -5.6% | ||
| Q2 25 | -19.5% | -5.0% | ||
| Q1 25 | -38.1% | -14.5% | ||
| Q4 24 | -15.1% | — | ||
| Q3 24 | -92.8% | -6.4% | ||
| Q2 24 | -169.6% | -8.7% |
每股收益（稀释后）ARQTRBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $0.14 | $0.50 | ||
| Q3 25 | $0.06 | $-0.07 | ||
| Q2 25 | $-0.13 | $-0.06 | ||
| Q1 25 | $-0.20 | $-0.15 | ||
| Q4 24 | $-0.09 | $0.05 | ||
| Q3 24 | $-0.33 | $-0.08 | ||
| Q2 24 | $-0.42 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.9M | $67.6M |
| 总债务越低越好 | $109.0M | — |
| 股东权益账面价值 | $189.5M | $419.1M |
| 总资产 | $433.0M | — |
| 负债/权益比越低杠杆越低 | 0.58× | — |
8季度趋势，按日历期对齐
现金及短期投资ARQTRBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | $42.9M | $96.4M | ||
| Q3 25 | $47.1M | $74.8M | ||
| Q2 25 | $72.7M | $60.5M | ||
| Q1 25 | $53.1M | $71.2M | ||
| Q4 24 | $71.3M | $87.8M | ||
| Q3 24 | $134.9M | $37.2M | ||
| Q2 24 | $84.3M | $64.6M |
总债务ARQTRBBN
| Q1 26 | — | — | ||
| Q4 25 | $109.0M | $342.1M | ||
| Q3 25 | $108.5M | $344.3M | ||
| Q2 25 | $108.0M | $346.5M | ||
| Q1 25 | $107.6M | $347.4M | ||
| Q4 24 | $107.2M | $348.3M | ||
| Q3 24 | $204.6M | $349.1M | ||
| Q2 24 | $203.8M | $350.0M |
股东权益ARQTRBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | $189.5M | $449.0M | ||
| Q3 25 | $158.1M | $360.1M | ||
| Q2 25 | $139.0M | $370.4M | ||
| Q1 25 | $142.7M | $381.8M | ||
| Q4 24 | $157.5M | $404.6M | ||
| Q3 24 | $156.6M | $395.5M | ||
| Q2 24 | $186.4M | $405.0M |
总资产ARQTRBBN
| Q1 26 | — | — | ||
| Q4 25 | $433.0M | $1.2B | ||
| Q3 25 | $371.0M | $1.1B | ||
| Q2 25 | $352.4M | $1.1B | ||
| Q1 25 | $344.1M | $1.1B | ||
| Q4 24 | $348.9M | $1.2B | ||
| Q3 24 | $437.4M | $1.1B | ||
| Q2 24 | $444.8M | $1.1B |
负债/权益比ARQTRBBN
| Q1 26 | — | — | ||
| Q4 25 | 0.58× | 0.76× | ||
| Q3 25 | 0.69× | 0.96× | ||
| Q2 25 | 0.78× | 0.94× | ||
| Q1 25 | 0.75× | 0.91× | ||
| Q4 24 | 0.68× | 0.86× | ||
| Q3 24 | 1.31× | 0.88× | ||
| Q2 24 | 1.09× | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.51× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ARQTRBBN
| Q1 26 | — | — | ||
| Q4 25 | $26.2M | $29.2M | ||
| Q3 25 | $-1.8M | $26.5M | ||
| Q2 25 | $324.0K | $-795.0K | ||
| Q1 25 | $-30.4M | $-3.5M | ||
| Q4 24 | $-748.0K | $61.8M | ||
| Q3 24 | $-34.7M | $-14.8M | ||
| Q2 24 | $-45.1M | $-9.8M |
自由现金流ARQTRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $27.3M | ||
| Q3 25 | — | $21.0M | ||
| Q2 25 | $246.0K | $-6.5M | ||
| Q1 25 | $-31.0M | $-15.7M | ||
| Q4 24 | — | $53.8M | ||
| Q3 24 | $-34.8M | $-23.7M | ||
| Q2 24 | — | $-12.9M |
自由现金流率ARQTRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | 9.7% | ||
| Q2 25 | 0.3% | -2.9% | ||
| Q1 25 | -47.1% | -8.7% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | -77.8% | -11.3% | ||
| Q2 24 | — | -6.7% |
资本支出强度ARQTRBBN
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.1% | 2.6% | ||
| Q1 25 | 0.9% | 6.7% | ||
| Q4 24 | 0.0% | 3.2% | ||
| Q3 24 | 0.3% | 4.2% | ||
| Q2 24 | 0.0% | 1.6% |
现金转化率ARQTRBBN
| Q1 26 | — | — | ||
| Q4 25 | 1.51× | — | ||
| Q3 25 | -0.24× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARQT
暂无分部数据
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
